Alcydons first GeoReactor X01, the first SolidHydrogen and the first BioSynfuel reactors will all be developped in Houston, TX . Our bionic model offers far more than just an energy solution; it can manage energy, water, and many other resources. The systems are capable of withstanding light to severe flooding and extreme storm surges. Furthermore, they offer the possibility of water storage as a redundant water reserve system for periods of mild to extreme drought. In parallel with storage, deep water purification can also take place, removing not only PFAS but also other chemical and/or pathogenic substances.

We are aiming for close cooperation with potential strategic partners. This opens up promising energy perspectives for all partners and can be easily scaled after the implementation of a pilot platform to offer other industrial users a cost-effective energy solution or even to provide "social energy" from the outset.

With this strategic move, we are making Houston, TX the primary site for Alcydon, from which our holistic vision of energy, health, and the environment can be fully developed.

Starting from an innovative starting point with an expected output soon, a modular high-tech follow-up is already being considered. Innovative medical radioisotopes could be produced there and distributed from here at lightning speed.

An advanced liver endocrine factor analog with capacity to mitigate blood sugar spikes and thus potentially contributing to logevity depending on current metabolic function and health pattern of the user.

Alcydon initiates research into to the relevance of developing a cell and gene therapy division. The aim is to achieve excellent, accessible and affordable solutions for everyone who needs them. In complete synergy and symmetry with the Alcydon XTL product line, 8 solutions will also be addressed here; namely CGT1, CGT2, CGT3, CGT4, CGT5, CGT6, CGT7 and CGT8. The last in line will be particularly focused on possible life extension.

Open for collaboration.

This research will investigate whether, in addition to potentially improved muscle integrity and strentgh, improved overall growth can also be achieved, and whether side effects of glucocorticoïds can be mitigated.

Open for collaboration.